DavidGeorgeBrachmanMD

Radiation Oncology • Phoenix, AZ

Physician

Join to view full profile

Are you Dr. Brachman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 102 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
350 W Thomas Rd
St Joes Rad/Onc Dept
Phoenix, AZ 85013
Phone+1 602-406-3170

Fax+1 602-406-4146
Is this information wrong?

Summary

Dr. David Brachman, MD is a radiation oncologist in Phoenix, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with St. Joseph's Hospital and Medical Center, Select Specialty Hospital-Phoenix, and Abrazo Arizona Heart Hospital.

Education & Training

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1987 - 1991
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1985
Loyola University Chicago Stritch School of MedicineClass of 1982

Certifications & Licensure

AZ State Medical License 1996 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Top Doctors:Arizona State Castle Connolly, 2013

Clinical Trials

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 3
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2006 Feb 09
Completed
Phase 1, Phase 2
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy Start of enrollment: 2007 May 01
Completed
Phase 2
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer Start of enrollment: 2008 Apr 01
Completed
Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
Recruiting
Phase 3
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma Start of enrollment: 2009 Jun 01
Completed
Phase 2
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Start of enrollment: 2009 Nov 17
Active, not recruiting
Phase 3
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer Start of enrollment: 2010 Oct 28
Completed
Phase 2
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20
Completed
Phase 2
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Start of enrollment: 2013 Jun 01
Completed
Phase 3
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Start of enrollment: 2014 Jun 30
Completed
Phase 2
Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device Start of enrollment: 2013 Apr 02
Completed
Join now to see all

Publications & Presentations

PubMed

4 citations
Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.
Kris Smith, Peter Nakaji, Theresa Thomas, Dilini Pinnaduwage, Garrick Wallstrom, Mehee Choi, Joseph Zabramski, Clark Chen, David Brachman> ;Neuro-Oncology. 2022 Nov 2
4 citations
Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors.
Dilini S Pinnaduwage, Shiv P Srivastava, Xiangsheng Yan, Shyam Jani, David G Brachman, Stephen P Sorensen> ;Technology in Cancer Research & Treatment. 2022 Jun 17
Resection and Surgically Targeted Brain Brachytherapy Without and With Systemic Therapy for Locally Recurrent GBM.
Peter Nakaji, David Brachman, Kris A. Smith, Theresa Thomas, Christopher Dardis, Dilini Pinnaduwage, G Wallstrom, C L Rogers, Emad Youssef> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
10 citations
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)
Jeffrey S. Wefel, Terri S. Armstrong, Stephanie L. Pugh, Mark R. Gilbert, Merideth M Wendland, David Brachman, Kevin S. Roof, Paul D. Brown, Ian R. Crocker, H. Ian Rob...> ;Neuro-Oncology. 2021 Jul 1
20 citations
Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial.
Peter Nakaji, Kris A. Smith, Emad Youssef, Theresa Thomas, Dilini Pinnaduwage, Leland Rogers, Garrick Wallstrom, David Brachman> ;Cureus. 2020 Nov 19
85 citations
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-...
Erica Hlavin Bell, Peixin Zhang, Edward G. Shaw, Jan C. Buckner, Geoffrey R. Barger, Dennis E. Bullard, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, Keith J. Stelz...> ;Journal of Clinical Oncology. 2020 Jul 24
37 citations
Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas
David Brachman, Emad Youssef, Christopher Dardis, Nader Sanai, Joseph M. Zabramski, Kris A. Smith, Andrew S. Little, Andrew G. Shetter, Theresa Thomas, Heyoung McBride...> ;Journal of Neurosurgery. 2019 Dec 1
27 citations
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therap...
Deborah T. Blumenthal, Minhee Won, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, Felix Bokstein, David G Brachman, Maria Werner-Wasik, Grant K. Hunter, Egils Valein...> ;Neuro-Oncology. 2018 Jun 18
5 citations
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
William A. Hall, Stephanie L. Pugh, Jeffrey S. Wefel, Terri Armstrong, Mark R. Gilbert, David Brachman, Maria Werner-Wasik, Merideth M Wendland, Paul D. Brown, Samuel ...> ;Neurosurgery. 2019 Jan 1
64 citations
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette, John De...> ;Journal of Neurosurgery. 2018 Jul 1
222 citations
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a p...
Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Marc Sanson, Alba A. Brandes, Paul Clement, Jean Francais Baurain, Warr...> ;Lancet. 2017 Oct 7
65 citations
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
Erica Hlavin Bell, Stephanie L. Pugh, Joseph P. McElroy, Mark R. Gilbert, Minesh P. Mehta, Alexander C. Klimowicz, Anthony M. Magliocco, Markus Bredel, Pierre A. Robe,...> ;JAMA Oncology. 2017 Jun 1
46 citations
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Susan M. Chang, Peixin Zhang, J. Gregory Cairncross, Mark R. Gilbert, Jean Paul Bahary, Carol A. Dolinskas, Arnab Chakravarti, Kenneth D. Aldape, Erica Hlavin Bell, Da...> ;Neuro-Oncology. 2016 Dec 18
75 citations
Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.
Robert M. Meier, Daniel A. Bloch, C. Cotrutz, Alan C. Beckman, G. Henning, S.A. Woodhouse, S. Williamson, Najeeb Mohideen, John J. Dombrowski, R.L. Hong, David Brachma...> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Oct 1
600 citations
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert, Geoffrey R. Barger, Stephen W. Coons, Peter Ricci, Dennis E. Bullard, Paul D. Br...> ;The New England Journal of Medicine. 2016 Apr 6
79 citations
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539
C. Leland Rogers, Arie Perry, Stephanie L. Pugh, Michael A. Vogelbaum, David Brachman, William McMillan, Joseph M. Jenrette, Igor J. Barani, Dennis C. Shrieve, Andy Sl...> ;Neuro-Oncology. 2016 Apr 1
In Reply to Brown et al.
David Brachman> ;International Journal of Radiation Oncology, Biology, Physics. 2016 Jan 1
20 citations
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: lo...
Michael A. Vogelbaum, Chen Hu, David M. Peereboom, David R. Macdonald, Caterina Giannini, John H. Suh, Robert B. Jenkins, Nadia N. Laack, David Brachman, Dennis C. Shr...> ;Journal of Neuro-Oncology. 2015 Jun 19
25 citations
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of R...
David Brachman, Stephanie L. Pugh, Lynn S. Ashby, Theresa Thomas, Erin M. Dunbar, Samir Narayan, H. Ian Robins, Joseph Bovi, Jason K. Rockhill, Minhee Won, Walter P. C...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Apr 1
99 citations
Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
Barbara Fisher, Chen Hu, David R. Macdonald, Glenn J. Lesser, Stephen W. Coons, David Brachman, Samuel Ryu, Maria Werner-Wasik, Jean Paul Bahary, Junfeng Liu, Arnab Ch...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Mar 1
176 citations
An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Mark E. Oppenlander, Andrew B. Wolf, Laura A. Snyder, Robert Bina, Jeffrey R. Wilson, Stephen W. Coons, David Brachman, Peter Nakaji, Randall W. Porter, Kris A. Smith,...> ;Journal of Neurosurgery. 2014 Apr 1
292 citations
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
J. Gregory Cairncross, Meihua Wang, Robert B. Jenkins, Edward G. Shaw, Caterina Giannini, David Brachman, Jan C. Buckner, Karen Fink, Luis Souhami, Normand Laperriere,...> ;Journal of Clinical Oncology. 2014 Mar 10
73 citations
Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02
Roshan S. Prabhu, Minhee Won, Edward G. Shaw, Chen Hu, David Brachman, Jan C. Buckner, Keith J. Stelzer, Geoffrey R. Barger, Paul D. Brown, Mark R. Gilbert, Minesh P. ...> ;Journal of Clinical Oncology. 2014 Feb 20
1835 citations
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pug...> ;The New England Journal of Medicine. 2014 Feb 19
21 citations
The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-contr...
Karen E. Hoffman, Stephanie L. Pugh, Jennifer L. James, Charles W. Scarantino, Benjamin Movsas, Richard K. Valicenti, André Fortin, Jondavid Pollock, Harold Kim, David...> ;Quality of Life Research. 2014 Feb 4
Join now to see all

Press Mentions

GT Medical Technologies Presents Clinical Data on GammaTile® Therapy for Brain TumorsAugust 24th, 2021
GT Medical Technologies Announces Four Clinical Abstracts at the 2021 ASCO Annual Meeting Related to GammaTile® Therapy for Brain TumorsJune 4th, 2021
Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results from a Prospective TrialNovember 19th, 2020
Join now to see all

Hospital Affiliations

Abrazo Arizona Heart HospitalPhoenix, Arizona
Banner Baywood Medical CenterMesa, Arizona
Carondelet St. Joseph's HospitalTucson, Arizona
Select Specialty Hospital-PhoenixPhoenix, Arizona
St. Joseph's Hospital and Medical CenterPhoenix, Arizona